Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
Digestive Diseases and Sciences
|
November 9, 2014
Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease
Heimo H Wenzl, Christian Primas, Gottfried Novacek, et al.
Inflammatory Bowel Diseases
|
August 20, 2010
Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases
Pavol Papay, Alexander Eser, Stefan Winkler, et al.
The American Journal of Gastroenterology
|
September 25, 2013
Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation
Sieglinde Angelberger, Walter Reinisch, Athanasios Makristathis, et al.
Zeitschrift Fur Gastroenterologie
|
November 9, 2023
[Use of subcutaneous Vedolizumab: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)]
Simon Reider, Gottfried Novacek, Thomas Haas, et al.
European Journal of Clinical Investigation
|
March 19, 2011
Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases
Pavol Papay, Alexander Eser, Stefan Winkler, et al.
The American Journal of Gastroenterology
|
December 17, 2009
The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery
Pavol Papay, Walter Reinisch, Elien Ho, et al.
Journal of Crohn'S & Colitis
|
May 28, 2013
Renal insufficiency in IBD--prevalence and possible pathogenetic aspects
Christian Primas, Gottfried Novacek, Karin Schweiger, et al.
The American Journal of Medicine
|
May 8, 2012
High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease
Pavol Papay, Klaus Hackner, Harald Vogelsang, et al.
Inflammatory Bowel Diseases
|
April 3, 2004
Infliximab: lack of efficacy on perforating complications in Crohn's disease
Wolfgang Miehsler, Walter Reinisch, Lili Kazemi-Shirazi, et al.
Journal of Crohn'S & Colitis
|
June 19, 2012
Tissue factor exposing microparticles in inflammatory bowel disease
Julia Palkovits, Gottfried Novacek, Marietta Kollars, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
Digestive Diseases and Sciences
|
November 9, 2014
Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease
Heimo H Wenzl, Christian Primas, Gottfried Novacek, et al.
Inflammatory Bowel Diseases
|
August 20, 2010
Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases
Pavol Papay, Alexander Eser, Stefan Winkler, et al.
The American Journal of Gastroenterology
|
September 25, 2013
Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation
Sieglinde Angelberger, Walter Reinisch, Athanasios Makristathis, et al.
Zeitschrift Fur Gastroenterologie
|
November 9, 2023
[Use of subcutaneous Vedolizumab: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)]
Simon Reider, Gottfried Novacek, Thomas Haas, et al.
European Journal of Clinical Investigation
|
March 19, 2011
Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases
Pavol Papay, Alexander Eser, Stefan Winkler, et al.
The American Journal of Gastroenterology
|
December 17, 2009
The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery
Pavol Papay, Walter Reinisch, Elien Ho, et al.
Journal of Crohn'S & Colitis
|
May 28, 2013
Renal insufficiency in IBD--prevalence and possible pathogenetic aspects
Christian Primas, Gottfried Novacek, Karin Schweiger, et al.
The American Journal of Medicine
|
May 8, 2012
High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease
Pavol Papay, Klaus Hackner, Harald Vogelsang, et al.
Inflammatory Bowel Diseases
|
April 3, 2004
Infliximab: lack of efficacy on perforating complications in Crohn's disease
Wolfgang Miehsler, Walter Reinisch, Lili Kazemi-Shirazi, et al.
Journal of Crohn'S & Colitis
|
June 19, 2012
Tissue factor exposing microparticles in inflammatory bowel disease
Julia Palkovits, Gottfried Novacek, Marietta Kollars, et al.
Page
of 7